Literature DB >> 1347638

Linking prescription and patient-identifying data: a pilot study.

S F Hurley1, J J McNeil, D J Jolley, R Harvey.   

Abstract

OBJECTIVE: To link a Pharmaceutical Benefits Scheme (PBS) prescription data set with patient-identifying data held by the Health Insurance Commission (HIC) and to then determine the prevalence of prescribing of cardiovascular drugs, non-steroidal anti-inflammatory drugs, hypnotics and minor tranquillizers, and diuretics (prescribed without other cardiovascular drugs) by age and sex in two defined populations.
DESIGN: Prescription data for a three-month period in 1985 were matched with patient-identifying information to obtain a database which included the patient's age, sex and an identifying number, for each prescription record. The percentages of the population taking a drug from each of the drug categories mentioned above were then determined and the effect of age, sex and region of residence on prescribing prevalence was investigated using logistic regression analysis.
SETTING: Two rural regions of Australia with a total population of 65,087 residents.
MEASUREMENTS AND MAIN RESULTS: Of the 101,383 prescriptions dispensed over the period 96% could be matched with HIC information. In the two regions combined, the percentages of the population taking a cardiovascular drug, non-steroidal anti-inflammatory drug, hypnotic or minor tranquilizer, or diuretic (without other cardiovascular drugs) were 10.4%, 5.8%, 3.5% and 2.5%, respectively. Prescribing rates were higher for females than males, increased with age and varied between the two regions. Approximately 5% of women aged 30-39 years were taking diuretics without other cardiovascular drugs, compared with only 0.2% of men in the same age group.
CONCLUSIONS: This pilot study illustrates the use of a patient-identified prescription database for drug utilisation review, therapeutic audit and hypothesis generation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347638     DOI: 10.5694/j.1326-5377.1992.tb139839.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes.

Authors:  M S Roberts; J A Stokes; M A King; T A Lynne; D M Purdie; P P Glasziou; D A Wilson; S T McCarthy; G E Brooks; F J de Looze; C B Del Mar
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 2.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

Review 3.  Women in clinical drug trials. An update.

Authors:  D L Schmucker; M S O'Mahony; E S Vesell
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

4.  The validity of a questionnaire on medicines used in health care practice: comparison of a questionnaire and computerized medical record survey.

Authors:  Ahmad Al-Windi
Journal:  Eur J Clin Pharmacol       Date:  2003-07-04       Impact factor: 2.953

5.  Socio demographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal.

Authors:  Indrajit Banerjee; Bedanta Roy; Brijesh Sathian; Indraneel Banerjee; Prasanta Kumar Chakraborty; Archana Saha
Journal:  BMC Psychiatry       Date:  2013-03-22       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.